Information:
Important update about weight loss medication, Tirzepatide
Patients may be aware that there is a national policy around the availability of weight loss medication to some patients in general practice from 23 June 2025, specifically Tirzepatide (or Mounjaro® as it is commonly known).
GPs in Lancashire and South Cumbria have not yet received confirmation that they will be commissioned to prescribe these medications.
This means that we are awaiting official guidance and commissioning updates and until we receive this confirmation, this medication is not currently available from the practice.
We will provide an update as soon as more information becomes available. In the meantime, we politely request that patients do not contact the practice about Tirzepatide.
Thank you for your understanding.
